investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Oncogenic Mechanisms and Molecular Targets in Lymphoma

Louis Staudt

8 Collaborator(s)

Funding source

National Cancer Institute (NIH)
Investigate lymphoma pathogenesis

Related projects

William Figg

Using Clinical Pharmacology Principles to Develop New Anticancer Therapies

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Louis Staudt

Molecular Diagnosis and Outcome Prediction in Lymphoma

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Andrew M Evens

MAP Kinase Signaling in Lymphoma: A Novel Therapeutic Paradigm

Non-Hodgkin lymphoma

Pathology

Ann M Moormann

Impact of Malaria on Shaping Immunity to EBV in the Etiology of Burkitt lymphoma

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Scott H Kaufmann

Anticancer Drug-Induced BH3-only Protein.Bak Interactions

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Eduardo Sotomayor

Research in Transformed and Aggressive B-cell lymphomas; Personalized Medicine Initiatives

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

George Thomas

The Function of rpL5 and rpL11 in Induction of p53

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Rosemary Rochford

Effects of Malaria on EBV Persistence in Children

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Roberto Chiarle

Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies